TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19775469

Group type: EXPERIMENTAL
Intervention: Postcard intervention sent monthly for 12 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 17521300

Group type: EXPERIMENTAL
Intervention: artemisinin
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: artemether
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: dihydroartemisinin
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: arteether
Number of subjects: 75
Study: 15363813

Group type: EXPERIMENTAL
Intervention: Night-time graded-release diltiazem (GRD) 360 mg
Number of subjects: 262

Group type: COMPARATOR
Intervention: Morning amlodipine 5 mg
Number of subjects: 262
Study: 12972704

Group type: EXPERIMENTAL
Intervention: Neoadjuvant systemic chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Radical cystectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pelvic lymphadenectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Systemic chemotherapy or combined radiochemotherapy
Number of subjects: 0
Study: 10604299

Group type: EXPERIMENTAL
Intervention: Topical carteolol hydrochloride 1.0%
Number of subjects: 100

Group type: COMPARATOR
Intervention: Topical timolol maleate 0.5%
Number of subjects: 100
Study: 7577850

Group type: EXPERIMENTAL
Intervention: Danazol (600 mg daily for 8 weeks, then 400 mg for 16 weeks)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Gestrinone (2.5 mg twice a week for 24 weeks)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Danazol
Number of subjects: 164

Group type: COMPARATOR
Intervention: Gestrinone
Number of subjects: 164
Study: 2036187

Group type: EXPERIMENTAL
Intervention: Dexamethasone (single intravenous dose)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 25
Study: 7033744

Group type: EXPERIMENTAL
Intervention: Sodium restriction
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 48
Study: 31250761

Group type: EXPERIMENTAL
Intervention: Viola odorata L. oil (20 drops) applied to the peripheral margin of the umbilicus
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Viola odorata L. oil
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 30552064

Group type: EXPERIMENTAL
Intervention: 600 IU vitamin D3
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: 2000 IU vitamin D3
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: 4000 IU vitamin D3
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Umbilical cord blood
Number of subjects: 360
Study: 28253584

Group type: EXPERIMENTAL
Intervention: General Anesthesia (GA)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Passive Restraint (PR)
Number of subjects: 61
Study: 25377359

Group type: EXPERIMENTAL
Intervention: Standard-dose ARA-C (SDAC)
Number of subjects: 130

Group type: COMPARATOR
Intervention: High-dose ARA-C (HDAC)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: SDAC-MRD(-)
Number of subjects: 130

Group type: COMPARATOR
Intervention: HDAC-MRD(-)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: SDAC-MRD(+)
Number of subjects: 130

Group type: COMPARATOR
Intervention: HDAC-MRD(+)
Number of subjects: 130
Study: 24752056

Group type: EXPERIMENTAL
Intervention: TRG 4 (complete regression)
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: TRG 2 and 3 (intermediate regression)
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: TRG 0 and 1 (poor regression)
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: Residual lymph node metastasis (ypN+)
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: Tumor regression grading (TRG)
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: ypN status
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: Lymphatic invasion
Number of subjects: 386
Study: 22802737

Group type: EXPERIMENTAL
Intervention: Community mobilization intervention in urban slum women's groups
Number of subjects: 18197

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 18197

Group type: EXPERIMENTAL
Intervention: Community mobilization intervention
Number of subjects: 18197
Study: 19900993

Group type: EXPERIMENTAL
Intervention: Insulin plus metformin (2000 mg)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Insulin plus repaglinide (6 mg)
Number of subjects: 102
Study: 17893258

Group type: EXPERIMENTAL
Intervention: Hyperinsulinaemic euglycaemic clamp (HEC)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Angiotensin II type 1 receptor blockade (losartan 200 mg) during hyperinsulinaemic euglycaemic clamp (AT-HEC)
Number of subjects: 8
Study: 15573713

Group type: EXPERIMENTAL
Intervention: Atazanavir (ATV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nelfinavir (NFV)
Number of subjects: 0
Study: 12477172

Group type: EXPERIMENTAL
Intervention: Two hearing aids
Number of subjects: 29

Group type: COMPARATOR
Intervention: One hearing aid
Number of subjects: 29
Study: 9454552

Group type: EXPERIMENTAL
Intervention: Side‐to‐end anastomosis
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Double stapling anastomosis
Number of subjects: 67

Group type: COMPARATOR
Intervention: End‐to‐end anastomosis
Number of subjects: 67
Study: 8284649

Group type: EXPERIMENTAL
Intervention: Cefcanel daloxate
Number of subjects: 400

Group type: COMPARATOR
Intervention: Amoxicillin
Number of subjects: 400
Study: 3424076

Group type: COMPARATOR
Intervention: Radiotherapy alone (41 patients)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Surgery and radiotherapy (47 patients)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Chemotherapy and radiotherapy (19 patients)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Transoral microlaryngoscopic laser resection and postoperative irradiation
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy
Number of subjects: 120
Study: 31409383

Group type: EXPERIMENTAL
Intervention: Continuous Resistance Training (CRT)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: High Intensity Interval Training (HIIT)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Moderate Intensity Continuous Training (MICT)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (CON) - seated rest
Number of subjects: 11
Study: 27603954

Group type: EXPERIMENTAL
Intervention: ACCS100 (3 g day-1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Calcium carbonate placebo (3 g day-1)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: ACCS100
Number of subjects: 50
Study: 24420638

Group type: EXPERIMENTAL
Intervention: 12-session reality therapy drug treatment program
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 40
Study: 24620447

Group type: EXPERIMENTAL
Intervention: Triple-drug therapy (OM 40/AML 10/HCTZ 25 mg)
Number of subjects: 369

Group type: COMPARATOR
Intervention: Dual therapies (OM 40/AML 10 mg, OM 40/HCTZ 25 mg, AML 10/HCTZ 25 mg)
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Triple-drug therapy
Number of subjects: 369

Group type: COMPARATOR
Intervention: Dual therapies
Number of subjects: 369
Study: 22503212

Group type: EXPERIMENTAL
Intervention: Cinacalcet 50 mg
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Cinacalcet 75 mg
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Cinacalcet 100 mg
Number of subjects: 38
Study: 19040270

Group type: EXPERIMENTAL
Intervention: Emotional eaters
Number of subjects: 21

Group type: COMPARATOR
Intervention: Nonemotional eaters
Number of subjects: 21
Study: 17323180

Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg/day
Number of subjects: 984

Group type: COMPARATOR
Intervention: Daily bisphosphonate (alendronate 10 mg/day or risedronate 5 mg/day)
Number of subjects: 984
Study: 15447752

Group type: EXPERIMENTAL
Intervention: scVSC
Number of subjects: 2056

Group type: COMPARATOR
Intervention: PVSC
Number of subjects: 2056

Group type: COMPARATOR
Intervention: AC
Number of subjects: 2056
Study: 11498460

Group type: EXPERIMENTAL
Intervention: Simvastatin and Niacin (S‐N)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Simvastatin and Niacin plus Antioxidants (S‐N+A)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 153
Study: 9663484

Group type: EXPERIMENTAL
Intervention: Combined neutralization of TNFalpha and interleukin-1 (IL-1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anti-TNFalpha monoclonal antibody treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anti-TNFalpha monoclonal antibody treatment with methotrexate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 0
Study: 8174061

Group type: EXPERIMENTAL
Intervention: Hyperfractionated radiation therapy (HFX) with brachytherapy; HFX doses of 1.2 Gy administered twice daily, total dose to the whole pelvis 24-48 Gy, followed by one or two intracavitary applications to deliver a total minimum dose of 85 Gy at point A and 65 Gy to lateral pelvic nodes.
Number of subjects: 81
Study: 2883990

Group type: EXPERIMENTAL
Intervention: Topical levobunolol 0.5%
Number of subjects: 46

Group type: COMPARATOR
Intervention: Topical metipranolol 0.6%
Number of subjects: 46
Study: 2033413

Group type: EXPERIMENTAL
Intervention: Alprazolam, 0.5 mg three times a day
Number of subjects: 147

Group type: COMPARATOR
Intervention: Progressive muscle relaxation (behavioral technique)
Number of subjects: 147
Study: 1107679

Group type: EXPERIMENTAL
Intervention: Radioisotope-powered pacemaker
Number of subjects: 60

Group type: COMPARATOR
Intervention: Chemical battery-powered pacemaker
Number of subjects: 60
Study: 31264506

Group type: EXPERIMENTAL
Intervention: New chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bayes factor
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Local Bayes false discovery rate
Number of subjects: 0
Study: 30677695

Group type: EXPERIMENTAL
Intervention: Robot-based intervention
Number of subjects: 23

Group type: COMPARATOR
Intervention: Human-based intervention
Number of subjects: 23
Study: 27860366

Group type: EXPERIMENTAL
Intervention: Intranasal sodium citrate (1 mL)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Physiological sodium chloride solution (1 mL, internal control)
Number of subjects: 49
Study: 25105320

Group type: EXPERIMENTAL
Intervention: Improved depression care
Number of subjects: 115
Study: 23811030

Group type: EXPERIMENTAL
Intervention: Multidisciplinary support programme (MSP)
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: MSP
Number of subjects: 447

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 447
Study: 21486801

Group type: EXPERIMENTAL
Intervention: Atorvastatin treatment for 3 months
Number of subjects: 9

Group type: COMPARATOR
Intervention: Arginase inhibition
Number of subjects: 9

Group type: COMPARATOR
Intervention: L-arginine supplementation
Number of subjects: 9

Group type: COMPARATOR
Intervention: Combined treatment (arginase inhibition plus L-arginine)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control sites (no treatment)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Arginase activity measurement
Number of subjects: 9
Study: 19681799

Group type: EXPERIMENTAL
Intervention: Midwestern Prevention Project (MPP) intervention condition
Number of subjects: 1002

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1002
Study: 16916336

Group type: EXPERIMENTAL
Intervention: Written action plans
Number of subjects: 139

Group type: COMPARATOR
Intervention: Usual practice
Number of subjects: 139
Study: 15518756

Group type: EXPERIMENTAL
Intervention: Azathioprine (AZA)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control group (not meeting selection criteria)
Number of subjects: 13
Study: 11387588

Group type: EXPERIMENTAL
Intervention: Exercise program (twice weekly group exercise)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Enriched food regimen (daily consumption of foods enriched with vitamins and minerals)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Control group (nonexercising groups followed a social program; nonsupplement groups received the same food products without the micronutrients)
Number of subjects: 157
Study: 9425385

Group type: EXPERIMENTAL
Intervention: Paracetamol (15 mg/kg)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Tepid sponging
Number of subjects: 80
Study: 8500241

Group type: EXPERIMENTAL
Intervention: Hydralazine and isosorbide dinitrate (Hyd-Iso)
Number of subjects: 1446

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1446

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 1446

Group type: COMPARATOR
Intervention: Prazosin
Number of subjects: 1446
Study: 3115372

Group type: EXPERIMENTAL
Intervention: HIV counselling and antibody testing during the campaign periods
Number of subjects: 700

Group type: COMPARATOR
Intervention: HIV counselling and antibody testing
Number of subjects: 700
Study: 30570787

Group type: EXPERIMENTAL
Intervention: Active treatment with high-dose hypoallergenic birch pollen allergoid
Number of subjects: 253

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 253
Study: 28068954

Group type: EXPERIMENTAL
Intervention: Cognitively and physically demanding exergame intervention (8-week duration, three sessions per week, 30 minutes each)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 66
Study: 26256133

Group type: EXPERIMENTAL
Intervention: 20-min massage (n = 61)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Social visit and relaxation session (no massage; n = 66)
Number of subjects: 127
Study: 23419987

Group type: EXPERIMENTAL
Intervention: NT‐pro‐BNP measured at rest, beginning of the test, maximal effort, and recovery phases
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: NT‐pro‐BNP measured at rest
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: ΔNT‐pro‐BNP from rest to the beginning phase
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: NT‐pro‐BNP at rest
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Maximal NT‐pro‐BNP
Number of subjects: 57
Study: 21123220

Group type: EXPERIMENTAL
Intervention: ICD therapy
Number of subjects: 10612

Group type: EXPERIMENTAL
Intervention: ICD therapy implanted later than 11 months after MI
Number of subjects: 10612
Study: 19242135

Group type: EXPERIMENTAL
Intervention: Parental factors (including parental alcohol use, socioeconomic status, and monitoring practices)
Number of subjects: 0
Study: 17184491

Group type: EXPERIMENTAL
Intervention: rosiglitazone 4 mg twice daily for 8 weeks
Number of subjects: 19

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 19
Study: 11864854

Group type: EXPERIMENTAL
Intervention: High dietary glycemic load
Number of subjects: 244

Group type: COMPARATOR
Intervention: Low dietary glycemic load
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: High dietary glycemic load among women with BMI ≥ 25
Number of subjects: 244

Group type: COMPARATOR
Intervention: Low dietary glycemic load among women with BMI ≥ 25
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: High dietary glycemic load among women with BMI < 25
Number of subjects: 244

Group type: COMPARATOR
Intervention: Low dietary glycemic load among women with BMI < 25
Number of subjects: 244
Study: 10216048

Group type: EXPERIMENTAL
Intervention: Lensectomy
Number of subjects: 65

Group type: COMPARATOR
Intervention: Aspiration with primary capsulotomy
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 65
Study: 7814635

Group type: EXPERIMENTAL
Intervention: Lipopeptide-based therapeutic vaccine (500 micrograms)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Lipopeptide-based therapeutic vaccine (5 and 50 micrograms)
Number of subjects: 26
Study: 2108855

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg rt-PA plus heparin over 4 h
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg rt-PA over 8 h, repeated in 24 h
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo plus heparin
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: 4-h infusion of rt-PA
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: 8-h infusion of rt-PA
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Greater than 50% lysis
Number of subjects: 83

Group type: COMPARATOR
Intervention: Less than 50% lysis
Number of subjects: 83
Study: 465276

Group type: EXPERIMENTAL
Intervention: Rapid release oxprenolol (160 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Slow release oxprenolol (160 mg)
Number of subjects: 0
Study: 29980388

Group type: EXPERIMENTAL
Intervention: Parental intention to vaccinate
Number of subjects: 765

Group type: EXPERIMENTAL
Intervention: Subjective norms related to daughter's doctor
Number of subjects: 765

Group type: EXPERIMENTAL
Intervention: Belief that the vaccine is safe
Number of subjects: 765

Group type: EXPERIMENTAL
Intervention: Self-efficacy to obtain the vaccine for their daughter
Number of subjects: 765

Group type: EXPERIMENTAL
Intervention: Parental concern about vaccine side effects
Number of subjects: 765

Group type: EXPERIMENTAL
Intervention: Intentions to vaccinate
Number of subjects: 765

Group type: EXPERIMENTAL
Intervention: Concern about sexual disinhibition
Number of subjects: 765
Study: 28965384

Group type: EXPERIMENTAL
Intervention: Phloroglucinol combined with parecoxib (80 mg phloroglucinol qd plus 40 mg parecoxib bid for 3 days)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Phloroglucinol only (80 mg phloroglucinol qd for 3 days)
Number of subjects: 98
Study: 24356622

Group type: EXPERIMENTAL
Intervention: panitumumab-FOLFIRI
Number of subjects: 1186

Group type: COMPARATOR
Intervention: FOLFIRI
Number of subjects: 1186
Study: 22286639

Group type: EXPERIMENTAL
Intervention: levocetirizine 5 mg
Number of subjects: 27

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 27
Study: 19711183

Group type: EXPERIMENTAL
Intervention: qEEG-based neurofeedback
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Remedial teaching
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (gender and age matched)
Number of subjects: 19
Study: 18293890

Group type: EXPERIMENTAL
Intervention: Early intracoronary injection of CD133+ cells
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Late intracoronary injection of CD133+ cells
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study: 15619071

Group type: EXPERIMENTAL
Intervention: Rosiglitazone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11853774

Group type: EXPERIMENTAL
Intervention: Blue-yellow color system
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Red-green color system
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Achromatic system
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chromatic system
Number of subjects: 0
Study: 10439740

Group type: EXPERIMENTAL
Intervention: Propofol (44 +/- 11 mg)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Propofol-ketamine (13.2 +/- 3.3 mg ketamine + 44 +/- 11 mg propofol)
Number of subjects: 70
Study: 8552459

Group type: EXPERIMENTAL
Intervention: Images stayed still
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Images moved in an unpredictable direction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Grey-out period introduced to mimic saccade
Number of subjects: 0
Study: 2333838

Group type: COMPARATOR
Intervention: Ordinary food coloring
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unusual food coloring
Number of subjects: 0

Group type: COMPARATOR
Intervention: 360 mg monosodium glutamate
Number of subjects: 0
Study: 375838

Group type: EXPERIMENTAL
Intervention: Low-dose heparin (L.D.H.) prophylaxis
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group (no low-dose heparin)
Number of subjects: 86
Study: 31761458

Group type: EXPERIMENTAL
Intervention: CliniPup® (Group A)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Empty game without educational information (Group B)
Number of subjects: 72

Group type: COMPARATOR
Intervention: No game, oral information at the outpatient clinic, current standard of care (Group C)
Number of subjects: 72
Study: 30945677

Group type: EXPERIMENTAL
Intervention: Crosses using four genotypes of cauliflower; F1, F2, BC1 and BC2 populations evaluated in a randomized block design.
Number of subjects: 0
Study: 29055221

Group type: EXPERIMENTAL
Intervention: Anterior plate fixation
Number of subjects: 78

Group type: COMPARATOR
Intervention: Stand-alone cage
Number of subjects: 78
Study: 24714934

Group type: EXPERIMENTAL
Intervention: Bazedoxifene 20 mg
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Bazedoxifene 40 mg
Number of subjects: 429

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Bazedoxifene 20 mg and 40 mg
Number of subjects: 429
Study: 23494465

Group type: EXPERIMENTAL
Intervention: Split circumferential semirigid cast
Number of subjects: 100

Group type: COMPARATOR
Intervention: Closed circumferential semirigid cast
Number of subjects: 100
Study: 21435024

Group type: EXPERIMENTAL
Intervention: Blue light treatment, three times weekly for four weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Red light treatment, three times weekly for four weeks
Number of subjects: 20
Study: 19686365

Group type: EXPERIMENTAL
Intervention: BoNT‐A 15 U
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BoNT‐A 30 U
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BoNT‐A 45 U
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18027255

Group type: EXPERIMENTAL
Intervention: PSA-based screening
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Screening for men aged 50-70 years
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Screening for men with familial risks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modern histopathological assessment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diagnosis of clinically significant cancers
Number of subjects: 0
Study: 15020177

Group type: EXPERIMENTAL
Intervention: Nutrition education program
Number of subjects: 866

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 866
Study: 12355029

Group type: COMPARATOR
Intervention: Smokers
Number of subjects: 2573
Study: 9802740

Group type: EXPERIMENTAL
Intervention: Repaglinide
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 2049255

Group type: EXPERIMENTAL
Intervention: Potassium chloride 32 mmol 12 hourly
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spironolactone 25 mg 12 hourly
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Potassium chloride vs Spironolactone
Number of subjects: 0